Nonhuman primates: translational models for predicting antipsychotic-induced movement disorders

Area of Science:

• Neuroscience
• Pharmacology
• Primate Models

Background:

• Antipsychotic medications can cause extrapyramidal symptoms.
• Drug-induced dystonia is a significant side effect observed in clinical practice.
• Rodent models for antipsychotic side effects may not fully capture complex human reactions.

Purpose of the Study:

• To investigate the utility of nonhuman primates (NHPs) as a model for antipsychotic-induced dystonia.
• To assess the translational validity of NHP dystonia for predicting clinical outcomes.
• To explore the potential of the NHP dystonia model as a biomarker for tardive dyskinesia.

Main Methods:

• Repeated administration of haloperidol to nonhuman primates over extended periods.
• Observation and documentation of orofacial and whole-body dystonic movements.
• Comparison of dystonia induction in NHPs with catalepsy induction in rodents.

Main Results:

• Chronic haloperidol treatment in NHPs induced gradual orofacial and whole-body dystonic reactions.
• The propensity to induce dystonia in NHPs was not correlated with catalepsy induction in rodents.
• These findings suggest dissociation between dystonia and catalepsy, indicating distinct extrapyramidal symptom aspects.

Conclusions:

• Antipsychotic-induced dystonia in NHPs demonstrates high translational validity due to homology with clinical phenomena.
• The NHP dystonia model can serve as a valuable tool for predicting movement disorders from novel antipsychotic drugs.
• This primate model may function as a biomarker for identifying substances likely to cause tardive dyskinesia in patients.